Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05323656
Title A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Genkyotex Suisse SA
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DEU

Additional content available in CKB BOOST